Vital Art and Science develops a smartphone-based home vision monitor called myVisionTrack for patients diagnosed with wet-AMD or diabetic retinopathy. myVisionTrack can be used in a physician’s office or at home to help track disease progression, detect condition changes for earlier intervention, and document treatment effects. The company was founded in 2006 by President Mike Bartlett and is based in Richardson, TX. Vital Art and Science completed a $550K Series A financing that valued the company at $10M post-money. The company intends to use the funds to continue development of its products and increase adoption among patients and clinicians. No operating metrics were reported in the article.

Total raised

$1M

Funding rounds

1

Latest round

Series A

Latest activity

Aug 2013